Magnesium Sulfate Demo

Magnesium sulfate, the active ingredient in Magnesium Sulfate Demo, is an electrolyte/mineral supplement presented as a sterile solution for intramuscular and intravenous use. It is employed to treat magnesium deficiency, prevent seizures in eclampsia and pre‑eclampsia, and act as a tocolytic in obstetric care.

GNH USA supplies Magnesium Sulfate Demo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate is an electrolyte/mineral supplement used in several obstetric, cardiac and respiratory conditions. - Eclampsia: prevents seizures in pregnant women with this life‑threatening condition. - Pre‑eclampsia: reduces the risk of progression to eclampsia by stabilising neuronal excitability. - Magnesium deficiency: restores normal serum magnesium levels and supports muscle and nerve function. - Torsades de pointes: shortens QT interval and helps terminate this ventricular arrhythmia. - Severe asthma exacerbations: provides bronchodilation and reduces airway hyper‑responsiveness. - Tocolysis: relaxes uterine smooth muscle to delay premature labor.

Adverse reactions may range from mild to life‑threatening and should be monitored during therapy.

Common Side Effects: - Flushing or warmth sensation - Sweating - Nausea or vomiting - Headache - Feeling of weakness or fatigue - Transient hypotension

Serious or Rare Side Effects: - Respiratory depression or arrest - Cardiac arrhythmias, including bradycardia - Severe hypotension - Loss of deep tendon reflexes - Anaphylactic reaction - Hypermagnesemia leading to neuromuscular blockade

Magnesium sulfate requires careful monitoring and specific clinical considerations. - Serum magnesium monitoring: adjust infusion rate to maintain therapeutic range. - Renal impairment: reduce dose or increase interval due to reduced clearance. - Myasthenia gravis: avoid because it may exacerbate muscle weakness. - Concurrent neuromuscular blockers: use with caution to prevent additive paralysis. - Calcium level assessment: correct hypocalcaemia before initiating therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Calcium channel blockers: additive vasodilatory effect may cause profound hypotension. - Neuromuscular blocking agents: potentiates muscle relaxation and risk of respiratory failure. - Aminoglycoside antibiotics: increased risk of neuromuscular blockade. - Loop diuretics: may enhance magnesium loss, complicating therapeutic monitoring. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may augment hypotensive response. - Beta‑blockers: combined effect on heart rate and blood pressure. - NSAIDs: can affect renal handling of magnesium. - Warfarin: rare reports of altered anticoagulation. - Antacids containing magnesium: monitor total magnesium load.